Pharmaceutical & Life Sciences News

Former Pharma CEO Gets Home Detention,
Probation, $20,000 Fine in Off-Label Case

April 15, 2011, 4:00 AM

SAN FRANCISCO—A federal judge April 13 sentenced InterMune founder W. Scott Harkonen to six months’ home detention and ordered him to pay a $20,000 fine on a jury verdict that the former chief executive officer committed wire fraud in issuing a false press release promoting off-label uses of the drug Actimmune (United States v. Harkonen).

Senior Judge Marilyn Hall Patel of the U.S. District Court for the Northern District of California rejected Department of Justice calls for extensive incarceration in the rare government prosecution of a CEO for promoting a drug for a use which it is unapproved....

To read the full article log in. To learn more about a subscription click here.